Publications by authors named "Dan Rathbone"

Claim this Profile
T
The development of a novel endovascular grasper for challenging inferior vena cava filter retrieval.
Cassius Iyad Ochoa Chaar, Valentyna Kostiuk, Paula Pinto Rodriguez, Tanner I Kim, Dan Rathbone

J Vasc Surg Venous Lymphat Disord· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A modified bonded model approach for molecular dynamics simulations of New Delhi Metallo-β-lactamase.
Amani A Eshtiwi, Dan L Rathbone

J Mol Graph Model· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, stability and efficacy of a new targeting peptide for nanoparticulate drug delivery to SH-SY5Y neuroblastoma cells.
Rachel Huey, Dan Rathbone, Paul McCarron, Susan Hawthorne

J Drug Target· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Potent and Selective Tissue Transglutaminase Inhibitors: Their Effect on TG2 Function and Application in Pathological Conditions.
Eduard Badarau, Zhuo Wang, Dan L Rathbone, Andrea Costanzi, Thomas Thibault

Chem Biol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationships of the N-terminus of calcitonin gene-related peptide: key roles of alanine-5 and threonine-6 in receptor activation.
Debbie L Hay, Paul W R Harris, Renata Kowalczyk, Margaret A Brimble, Dan L Rathbone

Br J Pharmacol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationships for α-calcitonin gene-related peptide.
Harriet A Watkins, Dan L Rathbone, James Barwell, Debbie L Hay, David R Poyner

Br J Pharmacol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imidazolium-based warheads strongly influence activity of water-soluble peptidic transglutaminase inhibitors.
Eduard Badarau, Alexandre Mongeot, Russell Collighan, Dan Rathbone, Martin Griffin

Eur J Med Chem· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indwelling catheters and medical implants with FXIIIa inhibitors: A novel approach to the treatment of catheter and medical device-related infections.
Nooshin Daneshpour, Russell Collighan, Yvonne Perrie, Peter Lambert, Dan Rathbone

Eur J Pharm Biopharm· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional characterization of two human receptor activity-modifying protein 3 variants.
Richard J Bailey, Joshua W I Bradley, David R Poyner, Dan L Rathbone, Debbie L Hay

Peptides· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-function analysis of RAMP1-RAMP3 chimeras.
Tao Qi, John Simms, Richard J Bailey, Mark Wheatley, Dan L Rathbone

Biochemistry· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis